Does Insulin Aspart Szjj Interact with Salicylates?
CDI records a moderate classification for Insulin Aspart Szjj and Salicylates. The stored summary is: May increase risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required. The mechanism involves increased blood glucose lowering effect. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Insulin Aspart Szjj Class
- Insulin Analog
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Increased blood glucose lowering effect
What To Tell Your Doctor or Pharmacist
If you are taking Insulin Aspart Szjj and your doctor is considering prescribing Salicylates (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider